HIV Prevention Shot Lenacapavir: Aspen Warns of Demand Risks

Original Article by Tamar Kahn | Business Day | 16 March 2026

Learn about the HIV prevention shot lenacapavir and why Aspen Pharmacare emphasises guaranteed demand for local production.

Learn about the HIV prevention shot lenacapavir and why Aspen Pharmacare emphasises guaranteed demand for local production.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Dis-Chem succession enters a new phase

The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.

Read more...

Ectopic pregnancy deaths expose care gaps

Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.

Read more...

Childhood immunisation coverage falls sharply in SA

Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.

Read more...